USA Financial Formulas’s Itron ITRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200
Closed -$21.7K 331
2024
Q4
$21.7K Buy
+200
New +$22.3K ﹤0.01% 266
2024
Q3
Sell
-543
Closed -$53.7K 319
2024
Q2
$53.7K Buy
+543
New +$54.6K 0.01% 225
2020
Q2
Sell
-2,447
Closed -$137K 281
2020
Q1
$137K Sell
2,447
-507
-17% -$38.5K 0.09% 115
2019
Q4
$248K Buy
+2,954
New +$233K 0.1% 120
2016
Q4
Sell
-9,672
Closed -$539K 302
2016
Q3
$539K Buy
9,672
+956
+11% +$45.8K 0.14% 127
2016
Q2
$376K Buy
+8,716
New +$368K 0.1% 160

Other funds holding ITRI

USA Financial Formulas's ITRI Position: Q1 2025 in Review

USA Financial Formulas sold out of Itron (ITRI) in Q1 2025, closing a stake of 200 shares — an estimated $21.7K sold.

USA Financial Formulas first reported a position in ITRI in Q2 2016 and held it in 6 quarters. The position peaked at $539K in Q3 2016. 426 funds tracked by Wall St. Rank hold ITRI as of Q1 2025.

  • USA Financial Formulas reported no remaining Itron position as of Q1 2025 after selling out during the quarter.
  • USA Financial Formulas sold 200 Itron shares in Q1 2025, an estimated $21.7K.
  • USA Financial Formulas first reported a position in Itron in Q2 2016 and held it in 6 quarters.
  • USA Financial Formulas's Itron position peaked at $539K in Q3 2016.
  • 426 funds tracked by Wall St. Rank held Itron as of Q1 2025.

Based on USA Financial Formulas's 13F filing for Q1 2025, filed 15 Apr 2025.